(19)
(11) EP 2 945 965 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.09.2018 Bulletin 2018/36

(45) Mention of the grant of the patent:
25.07.2018 Bulletin 2018/30

(21) Application number: 14703176.9

(22) Date of filing: 13.01.2014
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
(86) International application number:
PCT/IB2014/058234
(87) International publication number:
WO 2014/111841 (24.07.2014 Gazette 2014/30)

(54)

PEPTIDE

PEPTID

PEPTIDE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.01.2013 GB 201300683

(43) Date of publication of application:
25.11.2015 Bulletin 2015/48

(73) Proprietor: Apitope Technology (Bristol) Limited
Chepstow Gwent NP16 5UH (GB)

(72) Inventors:
  • WRAITH, David
    Bristol BS8 1TD (GB)
  • STREETER, Heather
    Bristol BS8 1TD (GB)
  • ORDONEZ, Laurence
    31840 Seilh (FR)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
WO-A1-96/32957
WO-A2-2008/055059
US-A1- 2007 055 049
 WO-A2-03/040165
WO-A2-2012/041867
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).